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cross-resistance to other antibiotic classes. CTZR may 
be due to AmpC or extended spectrum P-lactamases 
(ESBL). ESBL (+) GNB have been noted with in- 
creasing frequency in acute care and in outbreaks in NH. 
In our NH from 1995-97, rates of CTZR in clinical 
isolates were 10%. From ll/OO-3/02, screening of 1042 
GNB clinical isolates from our attached hospital yielded 
(8%) CTZR and 21 (2%) ESBL (+) isolates. Little is 
known about endemic colonization rates with CTZR 
GNB or ESBL in NH. Admissions to our NH were 
prospectively screened for GNB, CTZR, and ESBL 
every 2 weeks. Oropharynx, perineum, and wounds 
swabs were plated on MacConkey (Mac) agar. GNB 
were screened for CTZR on Mac+CTZ agar. Rectal 
swabs were plated directly on Mac+CTZ agar. CTZR 
GNB were screened for ESBL by double disk diffusion 
using CTZ or cefotaxime alone or in combination with 
clavulanate. 65 patients (pts) were screened on multiple 
occasions. 87 GNB isolates were detected in 38 pt (58%). 
GNB were found more often in pts with wounds, 
p=O.O5. Perineum (82%) and oropharynx (32%) were 
the most common sites of GNB colonization. Escherichia 
coli, Pseudomonas, Klebsiella, Proteus, Enterobacter, and 
Citrobacter were the most common genera isolated. 13 
(20%) of colonized pt had CTZR GNB, most commonly 
Pseudomonas or Enterobacter. Four pt (6%) had an 
ESBL (+) strain. No association with GNB, CTZR, or 
ESBL carriage could be made with age, declining func- 
tional status, increased length of stay, presence of devices, 
or co-morbid illness. Rates of colonization with ESBL 
producing CTZR GNB in NH may approach rates 
described in hospitals. 
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Background: Carbapenems and quinolones have a 
broad spectrum of antibacterial activity, and they are 
most potent agents used for chemotherapy of infectious 
disease caused by Gram-negative rods. Recently, how- 
ever, the emergence of the multidrug resistant Pseudo- 
monas aeruginosa (MDRP) is of utmost clinical concern, 
little information in regard to the distribution of MDRP 
in hospitals and the clinical characteristics of infected 
patients is available. To address this, we reviewed 
retrospectively the clinical charts of the patients infected 
with MDRP to clarify their clinical characteristics and 
significance in the hematological ward and screened the 
resistance gene. 
Methods: This study was conducted at Saitama Medical 
School Hospital in Saitama, Japan. We examined the 
antimicrobial susceptibilities of clinical isolates of 
MDRP, that were resistant to imipenem, amikacin, and 
ciprofloxacin, in hematological ward between 1999 
and 2001. Then we screened for the blarMp gene, which 
produced the metallo-beta-lactamase IMP-l. 
Results: A total of 16 isolated were detected in hema- 
tological disease patient in four years. We evaluated the 
clinical characteristics of 16 patients. MDRP organisms 
were isolated from stool sample (43.8%) urinary sample 
(25.0%) and respiratory sample (12.5%). Furthermore, 
the iatrogenic risk factor were anti-neoplastic agents 
(87.5%) IVH catheter (50.0%) steroids (43.8%), 
urinary catheter (43.8%). The clinical significance of 
detected MDRP was infection (25.0%) and colonization 
(68.8%). Infection was thought to have been the possible 
cause of death in 3 patients: clinical sepsis in two patient 
and terminal pneumonia in a patient. All isolations were 
detected the bluIMp gene. 
Conclusions MDRP is much detected from admini- 
stration of anti-neoplastic patients in hematological 
ward. Infection-related death was more frequent in case 
MDRP were detected in blood samples. 
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Background: Efforts to ensure provision of microbio- 
logically safe potable water for immunocompromised 
(IC) patients have focused on the elimination of C. 
parvum, although potable water may also contain oppor- 
tunistic pathogens such as Gram-negative environmental 
bacteria. In the UK, official guidelines advise patients 
with compromised T-cell function to drink only cooled 
boiled water (CBW). The provision of large quantities 
of CBW at one hospital in Leeds was identified as 
presenting a safety risk for health care personnel and 
safer alternatives were sought. 
Methods: A survey of provision of drinking water for IC 
patients throughout the Leeds Teaching Hospitals Trust 
was conducted. A range of options for potable water 
provision was then considered-CBW, carbonated and 
non-carbonated bottled water, sterile bottled water 
(SBW), mains water direct from the faucet (MW) and 
water filtered using commercial end-line filters (FW). 
The following criteria were examined: (1) microbio- 
logical safety, (2) end-user acceptability, (3) logistical 
considerations and (4) cost. 
Results: Marked disparities in practice were identified, 
e.g. some units that provided CBW used sterile jugs, 
whereas others did not. Other areas provided only 
MW. Provision of CBW to HIV positive patients com- 
